1. ‣Our Mission

We are initially targeting medical conditions in which the standard of care requires samples that are difficult, painful, invasive or dangerous to obtain and analyze as well as conditions for which no diagnostic tests currently exist.

Our principal targets include, infectious diseases, cancer, prenatal medicine, and organ transplant. Our mission is to significantly improve personalized medicine by developing disease and patient-specific urine-based molecular diagnostic tests to screen and monitor for DNA/RNA expression and/or mutations and micro-RNA (miRNA) signature profiles utilizing our proprietary nucleic acid technology.

1. •Develop novel urine-based (i.e. transrenal) nucleic acid tests to enhance personalized medicine
   

2. •When appropriate, partner with IVD companies to establish a global network for effective and efficient product development and commercialization. Collaborate with pharmaceutical companies to develop new tests that will facilitate targeted patient selection (cohorts) for clinical trials (i.e. based on patients’ expression profiles or mutation status for various biomarkers), increasing the likelihood of successful results while maximizing cost effectiveness.
   

3. •Maximize the adoption of our technology by clinical reference labs.
   

4. •Increase Shareholder value through effective execution of the aforementioned
   

» About Us

» Our Mission

» Business Strategy

» Management

» Board of Directors

TROV.PK

TrovaGene Inc., 11055 Flintkote Ave., Suite B, San Diego, CA 92121

Our mission is to apply our proprietary urine-based DNA/RNA/miRNA testing platform to develop highly sensitive, simple, convenient, rapid and completely non-invasive molecular diagnostics and advance the field of personalized medicine.

Our patented technology uses simple urine specimens and can be applied to a broad range of diseases and products addressing multi-billion dollar markets.

TROVAGENE INC (TROV.PK)